Biomedical Engineering Reference
In-Depth Information
117. Li H, Chen SJ, Chen YF, Meng QC, Durand J, Oparil S, Elton TS. Enhanced
endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J
Appl Physiol 1994; 77:1451-1459.
118. Minchenko A, Bauer T, Salceda S, Caro J. Hypoxic stimulation of vascular
endothelial growth factor expression in vitro and in vivo. Lab Invest 1994;
71:374-379.
119. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza
GL. Activation of vascular endothelial growth factor gene transcription by
hypoxia-inducible factor 1. Mol Cell Biol 1996; 16:4604-4613.
120. Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional reg-
ulation of the two vascular endothelial growth factor receptor genes. Flt-1, but
not Flk-1
=
KDR,
is up-regulated by hypoxia. J Biol Chem 1997; 272:
23659-23667.
121. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Me MG, Waltenber-
ger J, Voelkel NF, Tuder RM. Inhibition of the VEGF receptor 2 combined
with chronic hypoxia causes cell death-dependent pulmonary endothelial cell
proliferation and severe pulmonary hypertension. FASEB J 2001; 15:427-438.
122. Monge CC, Leon-Velarde F, Arregui A. Chronic mountain sickness in
andeans. In: Hombein TF, Schoene RB, eds. High Altitude. An Exploration
of Human Adaptation. New York: Marcel Dekker, Inc., 2001:815-838.
123. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-
term oxygen therapy can reverse the progression of pulmonary hypertension
in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis
1985; 131:493-498.
124. Voelkel NF, Tuder RM. Cellular and molecular mechanisms in the pathogen-
esis of severe pulmonary hypertension. Eur Respir J 1995; 8:2129-2138.
125. Li J, Perrella MA, Tsar JC, Yet SF, Hsieh CM, Yoshizumi M, et al. Induction
of vascular endothelial growth factor gene expression by interleukin-1 beta in
rat aortic smooth muscle cells. J Biol Chem 1995; 270:308-312.
126. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces
the expression of vascular endothelial growth factor. J Biol Chem 1996;
271:736-741.
127. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothe-
lial growth factor and its receptors and angiogenesis in bronchial asthma. J
Allergy Clin Immunol 2001; 107:1034-1038.
128. Clauss M, Gerlach M, Geriach H, Brett J, Wang F, Familletti PC, et al.
Vascular permeability factor: a tumor-derived polypeptide that induces
endotheilal cell and monocyte procoagulant activity, and promotes monocyte
migration. J Exp Med 1990; 172:1535-1545.
129. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migra-
tion of human monocytes in response to vascular endotheilal growth factor
(VEGF) is mediated via the VEGF receptor flt-1. Blood 1996; 87:3336-3343.
130. Barber` JA, Santos S, Peinado VI, Ramirez J, Morales J, Gimferrer JM, Roca
J, Rodriguez-Roisin R. Expression of vascular endotheilal growth factor
(VEGF) in pulmonary muscular arteries of COPD spectrum. Am J Respir Crit
Care Med 2001; 163:A123.
